QSS
NERV icon

Quantitative Systematic Strategies’s Minerva Neurosciences NERV Stock Holding History

Quantitative Systematic Strategies’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,404
Closed -$116K – 603
2020
Q1 		$116K Sell
2,404
-870
-27% -$52.5K 0.09% 225
2019
Q4 		$186K Buy
3,274
+1,229
+60% +$54.2K 0.03% 506
2019
Q3 		$127K Buy
2,045
+658
+47% +$37.3K 0.03% 430
2019
Q2 		$62K Buy
+1,387
New +$69.4K 0.01% 454
2019
Q1 		– Sell
-1,370
Closed -$74K – 554
2018
Q4 		$74K Buy
+1,370
New +$100K 0.02% 631

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantitative Systematic Strategies's NERV Position: Q2 2020 in Review

Quantitative Systematic Strategies sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 2,404 shares — an estimated $116K sold.

Quantitative Systematic Strategies first reported a position in NERV in Q4 2018 and held it in 5 quarters. The position peaked at $186K in Q4 2019. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

  • Quantitative Systematic Strategies reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,404 Minerva Neurosciences shares in Q2 2020, an estimated $116K.
  • Quantitative Systematic Strategies first reported a position in Minerva Neurosciences in Q4 2018 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Minerva Neurosciences position peaked at $186K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2020, filed 4 Aug 2020.